Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 16,020 | 0 | 0 | 0 |
| Gross Profit | N/A | 16,020 | N/A | N/A | N/A |
| Operating Expenses | 12,831 | 11,510 | 12,587 | 12,310 | 14,236 |
| Operating Income | -12,831 | 4,510 | -12,587 | -12,310 | -14,236 |
| Interest Expense | 20 | 21 | 11 | 9 | 7 |
| Other Income | 734 | 1,171 | 174 | -1,379 | 279 |
| Pre-tax Income | -12,117 | 5,660 | -12,424 | -13,697 | -13,963 |
| Income Tax | -1,282 | 2,065 | 90 | -113 | -193 |
| Net Income Continuous | -10,835 | 3,595 | -12,514 | -13,584 | -13,771 |
| Net Income | $-10,835 | $3,595 | $-12,514 | $-13,584 | $-13,771 |
| EPS Basic Total Ops | -2.60 | 0.93 | -24.25 | -166.97 | -514.13 |
| EPS Basic Continuous Ops | -2.60 | 0.93 | -23.26 | -167.03 | -514.31 |
| EPS Diluted Total Ops | -2.64 | 0.87 | -24.25 | -166.97 | -514.13 |
| EPS Diluted Continuous Ops | -2.64 | 0.87 | -23.26 | -167.03 | -514.31 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.87 | -24.21 | -166.97 | -637.26 |
| EBITDA(a) | $-12,806 | $4,634 | $-12,535 | $-12,268 | $-10,153 |